Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Teva Pharmaceutical: Clinical Trials & FDA Approval Profile

Teva Pharmaceutical (Tel Aviv, IL / Parsippany, NJ) sponsors 31 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 6 active protocols (1 recruiting now), 17 completed protocols, and 85 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)25.8%
Median Closed Enrollment vs National (145 pts)291 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Teva Pharmaceutical
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)31
Active Pipeline (Recruiting Now)6 (1)
Completed vs Stopped Early17 / 8 (25.8%)
Median Closed Actual Enrollment291 participants
Physical Hospital Site Disclosure34.5% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals85 (12 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Teva Pharmaceutical
Hospital Research SiteLocationShared Protocols
Washington University and Siteman Cancer CenterSaint Louis, MO3
UC San Diego Health and Moores Cancer CenterSan Diego, CA2

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Teva Pharmaceutical
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06568237A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System AtrophyPhase IIACTIVE NOT RECRUITING

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Teva Pharmaceuticals across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the Teva Pharmaceutical Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI